Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2014; 20(21): 6400-6411
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6400
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6400
Factor | ||
Antibiotics | Resistance to antibiotics | Clarithromycin |
Metronidazole | ||
Levofloxacin | ||
Amoxicillin | ||
Inhibition of acid secretion | CYP2C19 | Rapid metabolizer |
CYP2C19*17 | *17 carrier | |
ABCB1 3435 | C/C genotype (Caucasian) | |
IL-1B-511 | C/C genotype | |
IL-1B-31 | T/T genotype | |
Acid inhibitory drug dosing time | Low frequency (oid) | |
Acid inhibitory drug dosing dose | Insufficient dose | |
H. pylori phenotype | H. pylori virulence factors | cagA-negative |
vacA s2 genotype | ||
Environment | Volume | Much |
Smoking | Many | |
Compliance | Poor |
-
Citation: Sugimoto M, Furuta T. Efficacy of tailored
Helicobacter pylori eradication therapy based on antibiotic susceptibility andCYP2C19 genotype. World J Gastroenterol 2014; 20(21): 6400-6411 - URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6400.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6400